我们正在寻找中国人参与临床研究
News
AKL & HAM - 0800 788 3437
CHC & WLG - 0800 862 278

Important Information

If you are interested in applying for this study, please:
  • read the study description and study information document
  • review the Visit Planner dates in your location and confirm that you are available for the stated dates.
  • If you have not yet registered with us, click on the ‘Register’ button at the top of this page and answer the questions.
  • If you have already registered with us, answer the pre-screening questions listed below and submit your interest.

We will then contact you to check your suitability.

Study Description

New Zealand Clinical Research is conducting a pain tolerance study.

One in five New Zealanders live with persistent pain, making it hard to sleep, work and enjoy life. Current pain therapies are limited and may increase risk of abuse of dependence. There is a large unmet need for new, more effective pain therapies to be available to people who need them.

This study is evaluating the pain relief effect using a cold pressor test (CPT) in healthy males by comparing a pain medicine called suzetrigine (approved for use in the USA for acute and chronic pain, and licensed under the name Journavx) and comparing this to a placebo (a substance that looks like suzetrigine but contains no active medication). [OR This study is evaluating the pain relief effect using a cold pressor test (CPT) in healthy males by comparing a pain medicine and comparing this to a placebo.] The results of this study will help facilitate the design of studies with investigational pain medications.

This is an investigational medication because it has not been approved by MedSafe or other drug regulatory authorities in New Zealand.

This study LTG-OBS-103 is being funded by Latigo Therapeutics and has been approved by the Health and Disability Ethics Committee (HDEC).

Requirements

Healthy Males:

  • Aged between 18 – 55
  • BMI (Body Mass Index) between 18 – 32 kg/m2
  • Not currently taking any regular medications
  • Do not have any conditions which affect your skin on your arms and hands, or how you feel pain
  • Non-smoker/vaper/ OR No smoking or vaping in the last 14 days

What is Involved?

Study Visits: 2x 1-night stays + 1 clinic visit + 1 follow up phone call

Reimbursement: Up to $2,800 before tax

Important Documents

Important documents to download and read

Pre-screening Form

Ivy

Pre screening form for the Ivy study

Personal details

Please provide your name, email and phone number so we can contact you

Medical questions

This study requires the use of contraception during the study. If you are in a hetereosexual relationship both partners must agree to use contraception (condoms for males | IUD, birth control or another approved form for females). Are you currently using 2 forms of contraception?
Do you have any history of medical conditions relating to:
Have you donated blood or plasma in the last few months?
Do you have any history of allergies, asthma, hay fever, food allergies etc that you are aware of?
Have you taken any prescription, vitamins, supplements, pharmacy medication or over the counter medications in the last 14 days?
Just to inform you, that you come in for screening at risk. There is no payment for the screening visit, and you may not be offered a position on the study if the group fills up, or you may only be offered a position as a back-up. It is not guaranteed that you will get a full position on the study as it depends on your results as well. Are you comfortable with this?
Pre-screening form policy(Required)
I understand that by submitting this form, NZCR will use the information for pre-screening purposes for this study. This information may be recorded on your profile to allow us to improve our process when screening you for a future study. All information provided is confidential. I also understand that by submitting this form, I will be receiving emails, texts or calls about this study. For more information, please refer to the Privacy Policy.